News
company
year
domain
ProFound™ Therapeutics 06.12.2024
Metaphore Biotechnologies 05.09.2024
Prologue Medicines 05.07.2024
Repertoire® Immune Medicines 04.29.2024
Invaio Sciences 04.08.2024
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences